Your browser doesn't support javascript.
loading
Phase I study of combined indomethacin and platinum-based chemotherapy to reduce platinum-induced fatty acids.
van der Velden, Daphne L; Cirkel, Geert A; Houthuijzen, Julia M; van Werkhoven, E; Roodhart, Jeanine M L; Daenen, Laura G M; Kaing, Sovann; Gerrits, Johan; Verhoeven-Duif, Nanda M; Grootscholten, Cecile; Boot, Henk; Sessa, Cristisiana; Bloemendal, Haiko J; De Vos, Filip Y; Voest, Emile E.
Afiliação
  • van der Velden DL; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Cirkel GA; Division of Medical Oncology, Meander Medical Center, Amersfoort, The Netherlands.
  • Houthuijzen JM; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Werkhoven E; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Roodhart JML; Division of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Daenen LGM; Division of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Kaing S; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Gerrits J; Section Metabolic Diagnostics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Verhoeven-Duif NM; Section Metabolic Diagnostics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Grootscholten C; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Boot H; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Sessa C; Division of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Bloemendal HJ; Division of Medical Oncology, Meander Medical Center, Amersfoort, The Netherlands.
  • De Vos FY; Division of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Voest EE; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. e.voest@nki.nl.
Cancer Chemother Pharmacol ; 81(5): 911-921, 2018 05.
Article em En | MEDLINE | ID: mdl-29574584
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Protocolos de Quimioterapia Combinada Antineoplásica / Indometacina / Inibidores de Ciclo-Oxigenase / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Protocolos de Quimioterapia Combinada Antineoplásica / Indometacina / Inibidores de Ciclo-Oxigenase / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article